Background: Our previous data have indicated that nerve injury-induced up-regulation of thrombospondin-4 (TSP4) proteins in dorsal spinal cord plays a causal role in neuropathic pain state development in a spinal nerve ligation model. To investigate whether TSP4 proteins also contribute to the development of centrally mediated changes in nociception after spinal cord injury (SCI), we investigated whether SCI induced TSP4 dysregulation, and if so, whether this change correlated with changes in nociception in a T9 spinal cord contusion injury model. Methods: Behavioural sensitivity to mechanical, thermal stimuli and locomotor function recovery were tested blindly in SCI or sham rats post-injury. Intrathecal antisense or mismatch control oligodeoxynucleotides were used to treat SCI rats with nociceptive hyperreflexia, and Western blots were used to measure TSP4 protein levels in dorsal spinal cord samples. Results: SCI induced below-level hindpaw hypersensitivity to stimuli. TSP4 protein levels are up-regulated in dorsal spinal cord of SCI rats with nociceptive hyperreflexia, but not in SCI rats without nociceptive hyperreflexia. There was no significant difference in motor function recovery post-injury between SCI rats with or without nociceptive hyperreflexia. Intrathecal treatment with TSP4 antisense, but not mismatch control, oligodeoxynucleotides led to reversal of injury-induced TSP4 up-regulation and nociceptive hyperreflexia in SCI rats. Conclusions: SCI leads to TSP4 up-regulation in lumbar spinal cord that may play a critical role in mediating centrally mediated behavioural hypersensitivity. Blocking this pathway may be helpful in management of SCI-induced changes in nociception.
Introduction
Spinal cord injury (SCI) is a devastating event that results in motor dysfunction as well as development of chronic pain syndromes. There are approximately 600,000 individuals in the United States suffering from SCI, and about 60-80% SCI patients experience significant chronic pain (Yezierski, 1996; Finnerup et al., 2001; Jensen et al., 2009; Ataoglu et al., 2012; Celik et al., 2012) , which could be detected extensively as reflex hypersensitivity in animal models in the pain research field, possibly related to spinally mediated spasticity (Baastrup et al., 2010) . SCI-induced changes in nociception can reduce the quality of life of patients to a greater extent than motor impairment (Yezierski, 1996; Finnerup et al., 2001) . It tends to be long-term and difficult to manage, and often results in development of depression. The majority (83.2%) of the chronic pain is below the level of injury (Turner et al., 2001 ). Although pharmacological agents or non-pharmacological treatments could be used to relieve pain, none of them is highly specific and effective. Understanding the mechanism of post-SCI chronic pain therefore is critical for the development of next generation target-specific medications for SCI pain management.
Thrombospondin proteins (TSPs) are a family of large oligomeric, extracellular matrix glycoproteins that play important roles in cell attachment, migration and cytoskeletal dynamics (Bornstein et al., 2004) . Recently, it has been shown that TSPs induce synapse formation by interacting with its neuronal receptor, the calcium channel alpha-2-delta-1 subunit proteins (Eroglu et al., 2009 ). Previous studies indicated that spinal cord contusion injury causes up-regulation of the calcium channel alpha-2-delta-1 proteins at below-level in lumbar dorsal spinal cord (DSC; Boroujerdi et al., 2011) , which leads to the development of reduced paw withdrawal thresholds to mechanical stimuli, a widely accepted method for measuring nociceptive responses in animal models (Mills et al., 2001; Yoon et al., 2004; Boroujerdi et al., 2011) . In addition, peripheral nerve injury induces up-regulation of thrombospondin-4 (TSP4) proteins in DSC that plays a causal role in the development of neuropathic pain states in a peripheral nerve injury model (Kim et al., 2012) . However, it is not known if SCI also causes TSP4 up-regulation below-level in DSC that could play a critical role in mediating SCI-induced changes in nociception. In this study, we examined whether altered TSP4 expression in an SCI rat model plays an important role in mediating behavioural hypersensitivity.
Materials and methods
All experiments were performed with protocols approved by the Institutional Animal Care and Usage Committee of the University of California Irvine.
Spinal cord injury
Adult female Sprague Dawley rats (180-200 g) were anaesthetized with ketamine/xylazine (90:10 mg/kg). After the T8-11 region in the back was shaved and sterilized with Betadine (Swabsticks, Fisher Scientific, Hampton, NH, USA) followed by 75% ethanol, a midline incision was made and then T9 spinal cord was exposed by laminectomy. The contusion injury was generated by a 200-kilodyne weight-drop force onto the spinal cord from the distance of 3-4 mm using a Infinite Horizon device (Precision Systems and Instrumentation, LLC, Fairfax Station, VA, USA) (Scheff et al., 2003) . Sham rats were generated similarly as the SCI rats but without the spinal cord contusion. After the surgery, the incision was closed in two layers and the rats were placed on the heating pads for recovery. Post-operative care included daily subcutaneous injection of saline (10 mL) and Baytril (2.5 mg/kg/day; Western Medical Supplies, Arcadia, CA, USA) for 7 days to prevent dehydration and infection, respectively, as well as manual bladder expression for 10-14 days until the urination function was fully recovered, which varied among SCI rats but was not correlated with the development of abnormal behavioural sensitivity.
Locomotor function recovery test
The locomotor function was monitored using the Basso, Beattie and Bresnahan (BBB) locomotor rating scales (Basso et al., 1995) . Before surgery, the rats were acclimated to the environment by handing and patting for 10 min and exposing them to the testing apparatus (circular metal enclosure) for 20 min daily for 7 days. The baseline test was performed 3 days prior to the surgery. The post-operation testing began as soon as the rats could support their body weight. The locomotor function test scale ranged from 0 to 21, which focuses on the paw position, toe clearance, trunk stability and tail position, as described before (Basso et al., 1995) .
Behavioural testing
The 50% hindpaw withdrawal thresholds were measured blindly up to 40 days post-surgery, starting about 10 days after the surgery when the rats regained the ability to support their body weight, using a modified up-down method of Dixon (1980) . Baseline data were collected one day before the surgeries. Briefly, rats were randomly placed in the plastic enclosures on the top of an elevated wire mesh floor for at least 30-min acclimation. A series of von Frey filaments (Stoelting, Wood Dale, IL, USA), starting with the one providing a buckling force of 2.0 g, were then used to measure the degree of mechanical sensitivity. Each filament was applied in a perpendicular fashion to the plantar surface of each hindpaw. A sharp withdrawal or paw licking within 6 s was considered a positive response that led to the use of the next weaker filament. On the other hand, a negative response led to the application of the next larger filament. This paradigm was continued until six measurements were What's already known about this topic?
• It is known that peripheral nerve injury leads to thrombospondin-4 (TSP4) up-regulation in spinal astrocytes that plays a critical role in the development of neuropathic pain states.
What does this study add?
• Data from this study add that TSP4 is also up-regulated in the spinal cord after spinal cord injury, which may contribute to centrally mediated spinal cord injury-induced changes in nociception.
obtained starting from the one before the first change in response, or until four consecutive positive (scored 0.25 g) or five consecutive negative (scored 15 g) response were observed . Radiant heat plantar test was used to assess thermal sensitivity using a Hargreaves apparatus (Hargreaves et al., 1988) , and thermal hyperalgesia was considered as reduced hindpaw withdrawal latency to radiant heat stimulation. Briefly, individual free moving animals were acclimated for at least 30 min on the glass top of a hot box maintained at 30 Ϯ 0.1°C. Radiant heat from a high-intensity light bulb was projected through a small aperture below the glass surface to the plantar surface of the hindpaw. The time between the application of heat stimulus and withdrawal of the targeted hindpaw was recorded (paw withdrawal latency). A 20-s cut-off time was set to prevent thermal injury of the skin. Two readings per paw were averaged, and the values were used for statistical analysis.
Intrathecal injection
The sequences of TSP4 antisense and mismatch oligodeoxynucleotides used were derived from the rat TSP4 cDNA sequence (GenBank accession number: X89963).
Antisense: CCATCATTGTTGCTATCTTCC and mismatch: ACCATCGTTGTTACTTTCTCC oligodeoxynucleotides were ordered from GeneLink (Hawthorne, NY, USA), with modifications in both ends as described previously (Li et al., 2004; Boroujerdi et al., 2008; Kim et al., 2009 ). The oligodeoxynucleotides were precipitated and washed with 75% ethanol, then dissolved in sterile saline before use. Rats with hyperreflexic hindpaws (paw withdrawal threshold around or below 5 g) 40 days after SCI were anaesthetized with 2-3% isoflurane and a 25 gauge (1/2 in.) needle was inserted between lumbar 5-6 vertebrae. The solution (10 mL) was injected intrathecally (0.4 s/mL) using the microinjector (MINJ-PD micro-INJECTOR ALL-Digital Positive Dis-placement System, Tritech Research, Inc., Los Angeles, CA, USA). After each injection, the needle was held for 10-20 s to avoid the outflow of drug solutions. The daily injection was performed after daily behavioural testing for 4 consecutive days.
Western blot
Spinal cord samples were collected by hydraulic exclusion with ice-cold saline from deeply anaesthetized rats after decapitation at time points when some SCI rats had developed behavioural hypersensitivity (30-40 days post-SCI varying among different SCI groups), or one day after intrathecal treatments that correlated with the peak antinociceptive effects of TSP4 antisense oligodeoxynucleotide treatment. L4-6 DSC from both sides was dissected with a razor blade and stored at -80°C until use. Frozen L4-6 DSCs were pulverized and total proteins were extracted in 50 mmol/L Tris buffer, pH 7.5, containing 0.5% Triton X-100, 150 mmol/L NaCl, 1 mmol/L ethylenediaminetetraacetic acid and protease inhibitors. Protein concentrations were calculated using the bicinchoninic acid protein assay kit (Pierce, Rockford, IL, USA). Equal amounts of proteins were loaded into a NuPAGE 3-8% Tris-acetate gel (Invitrogen, Carlsbad, CA, USA). The protein bands were separated by electrophoresis and transferred onto a nitrocellulose membrane. After blocking non-specific binding sites with 5% low-fat milk in phosphatebuffered saline (PBS) containing 0.1% Tween 20 (PBS-T), the primary polyclonal antibody for TSP4 (1:750) (Kim et al., 2012) or monoclonal antibody for b-actin (1:10,000; Novus, Littleton, CO, USA) were used to probe the membranes in PBS-T for 1 h at room temperature or overnight at 4°C. Then, the membranes were washed three times in PBS-T and incubated with secondary antibody for 1 h in room temperature. The antibody-protein complexes were detected using a chemiluminescence reagent (Thermo Scientific, Rockford, IL, USA) followed by X-ray film exposure within the linear range of the X-ray films. The band densities were quantified using Kodak Image Analysis version 4.0. The ratio of TSP4 band density to that of b-actin within each sample was calculated for normalization of sample loading before cross-sample comparison analyses.
Statistic analysis
Data were presented as the means Ϯ standard error of the mean (SEM) and analysed by two-way analysis of variance for multi-group comparisons, or Student's t-test for two group comparisons as indicated. p-Value < 0.05 was considered a significant difference.
Results

SCI induced reduction of hindpaw reflex thresholds
As shown in Fig. 1 , SCI induced a gradual reduction in reflex thresholds below the injury level in the hindpaw of roughly half of the SCI rats 10 days postinjury. This is consistent with the reported observations in this model by different laboratories (Yoon et al., 2004; Boroujerdi et al., 2011) . The peak reduction in hindpaw reflex thresholds occurred approximately 4 weeks post-SCI. The slight reduction in reflex thresholds in the sham rats at some late time points may be due to increased stress level of these rats influenced by discomfort and ultrasonic vocalization of SCI rats tested blindly in the same room. Thermal hyperalgesia was also observed in the hindpaws of the SCI rats around the peak time point of hyperreflexic response (mean Ϯ SEM in paw withdrawal latency from hot box test: 10.32 Ϯ 0.10 s for naïve rats, n = 4; 5.54 Ϯ 0.25 s for SCI rats, n = 15. p < 0.001 by twotailed Student's t-test). The locomotor functional recovery scores indicated that there was no significant difference in the recovery of motor functions between SCI rats with or without reflex hypersensitivity at the peak time point of behavioural hypersensitivity (mean Ϯ SEM of BBB scores: 11.55 Ϯ 0.25 from n = 11 in non-hyperreflexic group; 11.75 Ϯ 0.22 from n = 12 in hyperreflexic group at 31 days post-SCI. p = 0.5398 by two-tailed Student's t-test). SCI did not cause behavioural hypersensitivity at (thoracic) or above (front paw) injury levels in this model when these rats were tested similarly as described but at different dermatomes (data not shown).
Up-regulated TSP4 proteins in SCI rats with reflex hypersensitivity
To determine whether SCI induced TSP4 upregulation in SCI rats that might have contributed to the changes in nociception, we examined the levels of TSP4 proteins in L4-6 DSC samples from sham and SCI rats with or without hyperreflexic hindpaws 30-40 days after surgery when reflex hypersensitivity was fully developed in about 50% of the SCI rats. As indicated in Fig. 2 , TSP4 protein levels were similar between naïve, sham and SCI rats without reflex hypersensitivity. Importantly, TSP4 protein levels were significantly increased in SCI rats with reflex hypersensitivity compared with that from naïve, sham and SCI rats without reflex hypersensitivity. The data indicated that TSP4 protein levels were significantly up-regulated in the DSC of SCI rats that correlated with reflex hypersensitivity development.
Intrathecal treatment with TSP4 antisense oligodeoxynucleotides in SCI rats resulted in a dose-dependent reversal of reflex hypersensitivity
To determine whether TSP4 proteins contributed to the development of reflex hypersensitivity after SCI, we injected TSP4 antisense oligodeoxynucleotides intrathecally (between L5/6) into SCI rats with reflex hypersensitivity daily for 4 days to see whether intrathecal TSP4 antisense oligodeoxynucleotide treatment could block SCI-induced changes in nociception. This treatment has been shown to block TSP4 expression and behavioural hypersensitivity in a peripheral Figure 1 Development of below-level hypersensitivity to mechanical stimulation in some spinal cord injury (SCI) rats. The 50% paw withdrawal thresholds to von Frey filament stimulation were examined at the hindpaws of SCI rats at designated time points. In sham rats, the hindpaw thresholds were between 10 and 15 g, similar to the pre-surgery level of naïve rats. Behavioural hyperreflexia as indicated by reduced paw withdrawal thresholds to von Frey filament stimulation (around or below 5 g) was developed in the hindpaws of approximately half of the SCI rats. Another half of the SCI rats had hindpaw sensitivity similar to that from the sham control. Data presented are the means Ϯ standard error of the mean from 34 rats in the pre-SCI groups, 15 rats in the sham group, 23 and 25 rats each in the hyperreflexic or non-hyperreflexic groups, respectively. **p < 0.01; ***p < 0.001 compared with the non-hyperreflexic group; # p < 0.05; ### p < 0.001 compared with day 10 post-injury as determined by two-way analysis of variance. Total proteins were extracted from L4-6 dorsal spinal cord after behavioural hypersensitivity was fully developed in some SCI rats (30-40 days after surgery varying among different SCI groups), and subjected to Western blot analysis for TSP4 protein levels. Representative Western blots were shown on top of each summarized bar graph (means Ϯ standard error of the mean) from three naïve rats, six each of the sham, SCI group with (hyperreflexic) or without (non-hyperreflexic) behavioural hypersensitivity. The ratio of TSP4 band density to that of b-actin within each sample was calculated for normalization of sample loading before cross-sample comparison analyses. **p < 0.01; ***p < 0.001 determined by Student's t-test.
nerve injury model (Kim et al., 2012) . Mismatch control oligodeoxynucleotides were used as controls. As shown in Fig. 3A , intrathecal treatment with 50 mg/ rat of TSP4 antisense oligodeoxynucleotides for 4 days led to a significant reversal of reflex hypersensitivity. The antisense effects had an onset time of 24 h, peaked approximately 1 day, and lasted for over 2 days after the last injection. Neither treatment with 10 mg/rat of TSP4 antisense oligodeoxynucleotides nor that with 50 mg/ rat of mismatch oligodeoxynucleotides could reverse SCI-induced reflex hypersensitivity significantly.
Intrathecal treatment with TSP4 antisense oligodeoxynucleotides in behaviourally hypersensitive SCI rats resulted in diminished TSP4 protein level in DSC
To confirm that the effects of intrathecal antisense oligodeoxynucleotide treatments were mediated through the antisense mechanism, we examined TSP4 protein levels in DSC after the 4-day antisense oligodeoxynucleotide treatment. As indicated in Fig. 3B , data from Western blot analysis indicated that DSC TSP4 protein levels were reduced about 40% after TSP4 antisense oligodeoxynucleotide treatment compared with mismatch oligodeoxynucleotide control treatment. This percentage reduction was similar to the percentage increase of TSP4 in DSC of SCI rats with reflex hypersensitivity shown in Fig. 2 .
Discussion
Over the last decades, several mechanisms have been proposed to explain the condition of pain following SCI, including loss of spinal inhibitory mechanisms (Shapiro, 1997; Siddall and Loeser, 2001) , synaptic plasticity (Shapiro, 1997; Yezierski, 2000) , astrocyte and microglia activation and changes in cell-signalling pathways at spinal and supraspinal sites (Yu and Yezierski, 2005; Crown et al., 2006; Hains and Waxman, 2006; Gwak et al., 2011) . We report here that SCI-induced elevation of thrombospondin-4 in DSC correlates with the development of behavioural hypersensitivity. Intrathecal treatment with TSP4 antisense oligodeoxynucleotides could reduce TSP4 expression and reverse SCI-induced behavioural hypersensitivity dose-dependently. These findings together suggest that SCI-induced TSP4 proteins in DSC may play a critical role in mediating SCI-induced changes in nociception. In our study, approximately 50% of SCI rats developed below-level behavioural hyperreflexia post-injury, similar to clinical observations that approximately a little more than half of SCI patients develop neuropathic pain and most of which is below the injury level (Siddall and Loeser, 2001; Turner et al., 2001) . As there is no apparent difference in (A) SCI rats with hyperreflexic hindpaws 40 days post-SCI were treated daily for 4 days with TSP4 antisense or mismatch oligodeoxynucleotides (50 mg/ rat/day) via direct intrathecal injection into the L5-6 region. Paw withdrawal thresholds (PWT) to von Frey filament stimulation were measured daily before the injection and continued after the last injection as indicated. Data presented are the means Ϯ standard error of the mean (SEM) from at least seven rats from each group except that three rats were in the mismatch oligodeoxynucleotide treatment group for day five and six after treatment initiation. **p < 0.01; ***p < 0.001 compared with pretreatment levels; and ## p < 0.01; ### p < 0.001 compared with the 50 mg/rat/day antisense oligodeoxynucleotide-treated group as determined by two-way analysis of variance. (B) Western blot analysis was used to measure TSP4 levels in dorsal spinal cord collected approximately 24 h after the last injection that correlated with the peak antinociceptive effects of TSP4 antisense oligodeoxynucleotide treatment. Representative Western blots were shown on top of each summarized bar graph presenting the means Ϯ SEM from five rats in each group. The ratio of TSP4 band density to that of b-actin within each sample was calculated for normalization of sample loading before cross-sample comparison analyses. *p < 0.05 compared with the mismatch oligodeoxynucleotide control treatment as determined by Student's t-test.
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motor function recovery between SCI rats with or without behavioural hypersensitivity, and we only test behavioural hypersensitivity after the recovery of SCI animals to a level in which they can support their body weights and walk several weeks post-injury (Fig. 1) , the development of below-level behavioural hypersensitivity is not likely due to changes in motor functions on SCI rats, in agreement with our previous findings (Boroujerdi et al., 2011) . Since intrathecal treatments with antisense, but not mismatch, oligodeoxynucleotides can reduce DSC TSP4 levels and reverse the established below-level behavioural hyperreflexia in a dose-dependent manner, our data support that SCI injury at the thoracic level leads to the development of below level neuroplasticity, including TSP4 overexpression, that contributes to the below-level SCI-induced changes in nociception. The mechanism underlying TSP4-mediated changes in nociception remains elusive. Data from recent studies have indicated that TSP proteins secreted from astrocytes play a critical role in inducing excitatory synapse formation in the central nervous system (Christopherson et al., 2005) by interacting with its receptor, the voltage-gated calcium channel alpha-2-delta-1 subunit proteins (Eroglu et al., 2009) . Interestingly, data from a peripheral nerve injury model have indicated that nerve injury increases TSP4 expression in activated DSC astrocytes, which leads to the development of neuropathic pain states (Kim et al., 2012) . In addition, SCI also causes up-regulation of the calcium channel alpha-2-delta-1 subunit protein in lumbar DSC that plays a critical role in the development of centrally mediated below-level neuropathic pain states (Boroujerdi et al., 2011) . Taken together, it is possible that SCI-induced TSP4 interacts with the calcium channel alpha-2-delta-1 subunit protein, leading to abnormal excitatory synaptogenesis and behavioural hypersensitivity. Further investigations to reveal the detailed mechanism related to the role of TSP4 induction in the development of SCI-induced behavioural hypersensitivity are warranted.
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